{"id":169808,"date":"2024-07-15T02:35:36","date_gmt":"2024-07-15T06:35:36","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/clene-announces-plans-to-submit-briefing-book-to-the-u-s-food-and-drug-administration-in-connection-with-granted-type-c-interaction-to-obtain-fda\/"},"modified":"2024-08-17T16:50:34","modified_gmt":"2024-08-17T20:50:34","slug":"clene-announces-plans-to-submit-briefing-book-to-the-u-s-food-and-drug-administration-in-connection-with-granted-type-c-interaction-to-obtain-fda","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medical-school\/clene-announces-plans-to-submit-briefing-book-to-the-u-s-food-and-drug-administration-in-connection-with-granted-type-c-interaction-to-obtain-fda.php","title":{"rendered":"Clene Announces Plans to Submit Briefing Book to the U.S. Food and Drug Administration in Connection with Granted Type C Interaction to Obtain FDA&#8230;"},"content":{"rendered":"<p><![CDATA[SALT LAKE CITY, July  11, 2024  (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, \u201cClene\u201d) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced plans to submit a briefing book by July 13 to the U.S. Food and Drug Administration (FDA) in advance of a granted Type C interaction. The purpose of the interaction with the FDA, to occur in the third quarter of 2024, is to receive feedback on the potential path to submission of a new drug application (NDA) for CNM-Au8\u00ae as a potential treatment for ALS via the accelerated approval pathway.]]><\/p>\n<p>View post:<br \/>\n<a target=\"_blank\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/07\/11\/2911858\/0\/en\/Clene-Announces-Plans-to-Submit-Briefing-Book-to-the-U-S-Food-and-Drug-Administration-in-Connection-with-Granted-Type-C-Interaction-to-Obtain-FDA-Feedback-on-Potential-Pathway-to-A.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Clene Announces Plans to Submit Briefing Book to the U.S. Food and Drug Administration in Connection with Granted Type C Interaction to Obtain FDA...\" rel=\"noopener\">Clene Announces Plans to Submit Briefing Book to the U.S. Food and Drug Administration in Connection with Granted Type C Interaction to Obtain FDA...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>View post: Clene Announces Plans to Submit Briefing Book to the U.S. Food and Drug Administration in Connection with Granted Type C Interaction to Obtain FDA... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medical-school\/clene-announces-plans-to-submit-briefing-book-to-the-u-s-food-and-drug-administration-in-connection-with-granted-type-c-interaction-to-obtain-fda.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[36],"tags":[],"class_list":["post-169808","post","type-post","status-publish","format-standard","hentry","category-medical-school"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/169808"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=169808"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/169808\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=169808"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=169808"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=169808"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}